10x Genomics CEO Sells $122,800 in Stock

Got story updates? Submit your updates here. ›

Serge Saxonov, the CEO of 10x Genomics (NASDAQ:TXG), sold 5,000 shares of the company's stock on Tuesday, April 14th. The shares were sold at an average price of $24.56, resulting in a total transaction of $122,800. Following the sale, Saxonov still directly owns 1,167,273 shares of the company's stock, valued at $28,668,224.88.

Why it matters

Insider transactions, such as stock sales by company executives, can provide insights into management's views on the company's prospects and valuation. While a single sale does not necessarily indicate a negative outlook, tracking insider activity can help investors assess sentiment and potential future performance.

The details

The stock sale was part of a series of transactions by Saxonov in recent months. On March 24th, he sold 5,000 shares at an average price of $19.52, and on March 23rd, he sold 10,000 shares at an average price of $19.13. Prior to that, on February 23rd, Saxonov sold 9,632 shares at an average price of $18.58.

• On April 14, 2026, Saxonov sold 5,000 shares at an average price of $24.56.
• On March 24, 2026, Saxonov sold 5,000 shares at an average price of $19.52.
• On March 23, 2026, Saxonov sold 10,000 shares at an average price of $19.13.
• On February 23, 2026, Saxonov sold 9,632 shares at an average price of $18.58.

What’s next

Investors will likely continue to monitor 10x Genomics' stock performance and any further insider transactions by Saxonov and other company executives to assess the company's outlook.